Farxiga Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

For udder instillation upon drying off only. Not to be used within six (6) weeks of freshening. Not for use in lactating cows. Milk taken from animals within 96 hours (8 milkings) after calving must not be used for food. Animals infused with this product must not be slaughtered for food within 60 days from time of infusion nor within 96 hours after calving.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


For intramammary use to reduce the frequency of existing infection and to prevent new infections with Staphylococcus aureus in dry cows.


There is currently no drug history available for this drug.

Other Information

Each 10 mL disposable syringe contains 1,000,000 units of Procaine Penicillin G, micronized, and 1 gram of Dihydrostreptomycin base, as Dihydrostreptomycin Sulfate, in an extended action base consisting of 1% w/v Hydrogenated Peanut Oil, 3% w/v Aluminum Monostearate, and Peanut Oil, q.s. Manufactured by a non-sterilizing process.

Farxiga Manufacturers

  • E.r. Squibb & Sons, L.l.c.
    Farxiga (Dapagliflozin) Tablet, Film Coated [E.r. Squibb & Sons, L.l.c.]

Login To Your Free Account